BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8744797)

  • 1. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
    Broich G; Lavezzi AM; Biondo B; Pignataro LD
    In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCNA--a cell proliferation marker in vocal chord cancer. Part I: Premalignant laryngeal lesions.
    Pignataro LD; Broich G; Lavezzi AM; Biondo B; Ottaviani F
    Anticancer Res; 1995; 15(4):1517-20. PubMed ID: 7654040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
    Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
    Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
    Franchi A; Gallo O; Boddi V; Santucci M
    Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological study on the proliferation and differentiation of laryngeal carcinoma and dysplasia].
    Kusaba Y
    Fukuoka Igaku Zasshi; 1992 Dec; 83(12):426-33. PubMed ID: 1292964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The proliferative activity of laryngeal carcinoma and its relationship to histological malignancy and prognosis].
    Zhang Q; Li Y; Liu J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(5):305-7. PubMed ID: 8762515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations.
    Tomasino RM; Daniele E; Bazan V; Morello V; Tralongo V; Nuara R; Nagar C; Salvato M; Ingria F; Restivo S
    Cancer Res; 1995 Dec; 55(24):6103-8. PubMed ID: 8521400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
    Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
    Zhou G; Lin D; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
    Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
    Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Tai Y; Sugimoto K; Hirao T; Tokuda M
    Clin Cancer Res; 2000 Nov; 6(11):4253-8. PubMed ID: 11106240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunohistochemical expression of p21WAF1/Cip1 and Proliferating cell nuclear antigen in laryngeal squamous cell carcinomas.
    Li X; Izumaru S; Sakamoto K; Miyajima Y; Nakashima T
    J Laryngol Otol; 2006 Dec; 120(12):1042-8. PubMed ID: 16995968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
    Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
    Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of apoptosis and proliferation related genes in carcinogenesis of lung squamous cell carcinoma in rats].
    Wang J; Chen HL; Zhu RQ; Diao LM; Jang M; Yang F; Liu MQ
    Ai Zheng; 2003 May; 22(5):471-6. PubMed ID: 12753705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma].
    Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ
    Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.
    Cordes C; Münzel AK; Rudolph P; Hoffmann M; Leuschner I; Gottschlich S
    Anticancer Res; 2009 Apr; 29(4):1459-65. PubMed ID: 19414402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.